Cardinal Health recalls some Monoject syringes

Cardinal Health today announced it has issued a voluntary recall, in coordination with the FDA, for all sizes of its branded Monoject Luer-Lock Soft Pack Sterile Syringes and Monoject Enteral Sterile Syringes with the ENFit connection, due to an issue where new product dimensions may not be fully compatible with pumps.

The company is urging patients and providers to not use the affected syringes and follow instructions from Cardinal Health to return any inventory they currently have. The product removal is lot-specific, with impacted product codes listed on Cardinal Health’s site. Older Covidien brand Monoject syringes are not included in this recall.

The issue stems from the company’s release of “Cardinal Health”-branded Monoject syringes in June 2023, which were manufactured by a different contractor and differed slightly in dimensions from the “Covidien”-branded syringes. 

These small changes in size may cause issues with syringe pumps, PCA pumps and enteral syringe pumps performing as expected. Cardinal Health said it had received 15 reports of delayed therapy because syringe infusion pumps did not recognize the new syringes, and 13 reports of inaccurate dosing, which included some injuries, though no reported deaths.

Cardinal Health had issued a previous product correction related to the issue late last year, and said the current expansion to full product removal was designed to reduce confusion for customers. The company said it plans to work with the FDA and manufacturers to reintroduce Cardinal Health branded Monoject syringes in the future.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”